MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

WuXi PharmaTech (Cayman) Company Profile (NYSE:WX)

Consensus Ratings for WuXi PharmaTech (Cayman) (NYSE:WX) (?)
Ratings Breakdown: 3 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $40.75 (11.22% downside)

Analysts' Ratings History for WuXi PharmaTech (Cayman) (NYSE:WX)
Show:
DateFirmActionRatingPrice TargetActions
10/5/2015Morgan StanleyDowngradeOverweight -> Equal WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2015William BlairReiterated RatingOutperform -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/12/2015Credit SuisseDowngradeOutperform -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2015Morgan StanleyReiterated RatingOverweight$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Goldman SachsDowngradeConviction-Buy -> Neutral$44.50 -> $39.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/21/2014Jefferies GroupDowngradeBuy -> Hold$40.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2014Goldman SachsUpgradeNeutral -> Conviction-BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2014Morgan StanleyReiterated RatingOverweight$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2014OppenheimerBoost Price TargetOverweight$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/11/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha